Reports Q1 revenue $355.4M, consensus $352.57M. “We delivered better-than-expected financial performance in the first quarter, with our constant currency revenue, organic, our constant currency total revenue and our non-GAAP EPS exceeding the high-end of our expectations,” said Fred Lampropoulos, Merit’s CEO. “We also delivered impressive year-over-year improvements in our non-GAAP operating margin and our non-GAAP earnings per share, which increased 229 basis points and 15%, respectively, year-over-year.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target lowered to $112 from $116 at Piper Sandler
- MMSI Earnings this Week: How Will it Perform?
- Buy Rating for Merit Medical Systems: Strong Revenue Growth and Strategic Initiatives Drive Optimism
- Merit Medical launches Ventrax Delivery System
- Merit Medical Systems: Strategic Positioning and Innovation Drive Buy Rating